Micro-thin prescription inserts an option for keratoconus

Editor's Note: Addition Technology Inc., the manufacturer of Intacs micro-thin prescription inserts for surgical vision correction, announced Aug. 4 that it had received approval from the FDA for a Humanitarian Device Exemption to market the inserts for the treatment of keratoconus. Dr. Rabinowitz's presentation was given earlier this year at the American Society of Cataract and Refractive Surgery meeting.

San Diego-Micro-thin prescription inserts (Intacs, Addi- tion Technology Inc.) can be successfully used to treat patients with keratoconus em- ploying the IntraLase femtosecond laser (IntraLase Corp.), reported Yaron S. Rabinowitz, MD, during the American Society of Cataract and Refractive Surgery annual meeting.

"The primary goal is to make the patients who are contact lens-intolerant, contact lens-tolerant and to prevent the need for a corneal transplant," Dr. Rabinowitz said.